• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观点——新生儿Fc受体转运白蛋白:与免疫学和医学的相关性

Perspective-- FcRn transports albumin: relevance to immunology and medicine.

作者信息

Anderson Clark L, Chaudhury Chaity, Kim Jonghan, Bronson C L, Wani Manzoor A, Mohanty Sudhasri

机构信息

Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Trends Immunol. 2006 Jul;27(7):343-8. doi: 10.1016/j.it.2006.05.004. Epub 2006 May 30.

DOI:10.1016/j.it.2006.05.004
PMID:16731041
Abstract

Recent evidence validates a forgotten 40-year-old hypothesis: the MHC-related Fc receptor for IgG (FcRn) protects albumin from intracellular catabolic degradation, as it does for IgG, accounting for the uniquely long half-lives of both molecules and explaining their direct concentration-catabolism relationships. Albumin and IgG bind to FcRn at low pH but not at physiological pH. These two ligands bind independently of one another by distinctive mechanisms and to different surfaces of the receptor. Kinetic studies of FcRn-deficient mice indicate that, at steady-state, FcRn salvages from the degradative pathway a similar amount of albumin as is produced by mice and almost four-times more IgG than is produced. Thirty-fivefold more albumin than IgG molecules are protected from degradation by FcRn per unit time. It can be inferred that FcRn is expressed in nearly all cells. This receptor, originally described as transporting IgG from the mother to the fetus or neonate, now has a wider role central to the homeostatic regulation and conservation of both albumin and IgG throughout life.

摘要

近期证据证实了一个被遗忘40年的假说:与主要组织相容性复合体(MHC)相关的IgG Fc受体(FcRn)如同保护IgG一样,可保护白蛋白免于细胞内分解代谢降解,这解释了这两种分子独特的长半衰期,并说明了它们直接的浓度-分解代谢关系。白蛋白和IgG在低pH值下与FcRn结合,但在生理pH值下不结合。这两种配体通过独特机制彼此独立结合至受体的不同表面。对FcRn缺陷型小鼠的动力学研究表明,在稳态下,FcRn从降解途径挽救的白蛋白量与小鼠产生的白蛋白量相似,挽救的IgG量几乎是小鼠产生量的四倍。每单位时间内,被FcRn保护免于降解的白蛋白分子数量是IgG分子数量的35倍。可以推断,FcRn在几乎所有细胞中均有表达。这种受体最初被描述为将IgG从母体转运至胎儿或新生儿,现在在白蛋白和IgG终身稳态调节与保存方面发挥着更广泛的核心作用。

相似文献

1
Perspective-- FcRn transports albumin: relevance to immunology and medicine.观点——新生儿Fc受体转运白蛋白:与免疫学和医学的相关性
Trends Immunol. 2006 Jul;27(7):343-8. doi: 10.1016/j.it.2006.05.004. Epub 2006 May 30.
2
Albumin binding to FcRn: distinct from the FcRn-IgG interaction.白蛋白与新生Fc受体的结合:不同于新生Fc受体与免疫球蛋白G的相互作用。
Biochemistry. 2006 Apr 18;45(15):4983-90. doi: 10.1021/bi052628y.
3
Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice.胎儿和新生小鼠获取母体IgG对β2-微球蛋白相关Fc受体的需求。
J Immunol. 1995 Jun 15;154(12):6246-51.
4
Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.β2-微球蛋白缺陷小鼠比FcRn-α链缺陷小鼠更快地分解代谢IgG。
Exp Biol Med (Maywood). 2008 May;233(5):603-9. doi: 10.3181/0710-RM-270. Epub 2008 Mar 28.
5
An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta.一种在人胎盘合体滋养层细胞中表达的IgG转运性Fc受体。
Eur J Immunol. 1996 Jul;26(7):1527-31. doi: 10.1002/eji.1830260718.
6
FcRn binding properties of an abnormal truncated analbuminemic albumin variant.异常截断性无白蛋白血症白蛋白变体的 FcRn 结合特性。
Clin Biochem. 2010 Mar;43(4-5):367-72. doi: 10.1016/j.clinbiochem.2009.12.001. Epub 2009 Dec 16.
7
The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.人类新生儿Fc受体重链中保守的组氨酸166残基对于其与白蛋白的pH依赖性结合至关重要。
Eur J Immunol. 2006 Nov;36(11):3044-51. doi: 10.1002/eji.200636556.
8
FcRn: the neonatal Fc receptor comes of age.FcRn:新生儿Fc受体步入成熟阶段。
Nat Rev Immunol. 2007 Sep;7(9):715-25. doi: 10.1038/nri2155. Epub 2007 Aug 17.
9
A strategy for bacterial production of a soluble functional human neonatal Fc receptor.一种用于细菌生产可溶性功能性人新生儿Fc受体的策略。
J Immunol Methods. 2008 Feb 29;331(1-2):39-49. doi: 10.1016/j.jim.2007.11.003. Epub 2007 Dec 10.
10
The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics.多功能 MHC 类 I 相关 FcRn 保护 IgG 和白蛋白免受降解:对开发新的诊断和治疗方法的影响。
Drug Metab Pharmacokinet. 2009;24(4):318-32. doi: 10.2133/dmpk.24.318.

引用本文的文献

1
The FcRn from gene to protein and function: comparison between species.从基因到蛋白质及功能的新生儿Fc受体:物种间比较
Front Immunol. 2025 Aug 1;16:1608426. doi: 10.3389/fimmu.2025.1608426. eCollection 2025.
2
The neonatal Fc receptor (FcRn): Guardian or Trojan Horse in viral infection?新生儿Fc受体(FcRn):病毒感染中的守护者还是特洛伊木马?
PLoS Pathog. 2025 Jul 7;21(7):e1013285. doi: 10.1371/journal.ppat.1013285. eCollection 2025 Jul.
3
Wolf in Sheep's Clothing: Taming Cancer's Resistance with Human Serum Albumin?披着羊皮的狼:用人血清白蛋白驯服癌症的耐药性?
Int J Nanomedicine. 2025 Mar 19;20:3493-3525. doi: 10.2147/IJN.S500997. eCollection 2025.
4
Targeted Treatment of Sarcomas by Single Protein Encapsulated Doxorubicin with Undetectable Cardiotoxicity and Superior Efficacy.单蛋白包裹阿霉素对肉瘤进行靶向治疗,具有不可检测的心脏毒性和卓越疗效。
Cancers (Basel). 2025 Mar 4;17(5):881. doi: 10.3390/cancers17050881.
5
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.利用 NALT 和 BALT 的潜力,通过工程策略作为免疫调节的靶点,以增强黏膜摄取。
Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024.
6
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.一种经工程改造的泛严重急性呼吸综合征冠状病毒2特异性可溶性血管紧张素转换酶2-白蛋白融合蛋白,旨在延长血浆半衰期并实现无针黏膜递送。
PNAS Nexus. 2023 Nov 28;2(12):pgad403. doi: 10.1093/pnasnexus/pgad403. eCollection 2023 Dec.
7
Single protein encapsulated SN38 for tumor-targeting treatment.载单蛋白 SN38 的肿瘤靶向治疗。
J Transl Med. 2023 Dec 10;21(1):897. doi: 10.1186/s12967-023-04778-0.
8
Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses.鼻腔内接种 RBD-血凝素融合蛋白利用了预先存在的免疫来增强抗原特异性反应。
J Clin Invest. 2023 Dec 1;133(23):e166827. doi: 10.1172/JCI166827.
9
Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.利用基于白蛋白的药物递送系统克服血脑屏障治疗脑癌的最新进展与策略,重点关注胶质母细胞瘤
Polymers (Basel). 2023 Oct 2;15(19):3969. doi: 10.3390/polym15193969.
10
Novel albumin-binding multifunctional probe for synergistic enhancement of FL/MR dual-modal imaging and photothermal therapy.用于协同增强荧光/磁共振双模态成像及光热治疗的新型白蛋白结合多功能探针。
Front Chem. 2023 Aug 1;11:1253379. doi: 10.3389/fchem.2023.1253379. eCollection 2023.